Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in structure-based rational drug design.

P J Gane1, P M Dean

  • 1De Novo Pharmaceuticals Ltd., Cambridge, UK. paul.gane@ddg.phar.cam.ac.uk

Current Opinion in Structural Biology
|September 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pyridylthioacetmorpholides and pyridylacetic acids.

Journal of the American Chemical Society·2010
Same author

Chemical genomics: a challenge for de novo drug design.

Molecular biotechnology·2007
Same author

The impact of epilepsy surgery on quality of life in children.

Neurology·2006
Same author

Industrial-scale, genomics-based drug design and discovery.

Trends in biotechnology·2001
Same author

Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE.

Journal of medicinal chemistry·2001
Same author

SLATE: a method for the superposition of flexible ligands.

Journal of computer-aided molecular design·2001

Structure-based drug design integrates compound docking and in situ molecular assembly. Understanding drug-protein complex structures is crucial for modern drug discovery.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Drug discovery relies heavily on understanding molecular interactions.
  • Structure-based drug design (SBDD) utilizes the three-dimensional structure of biological targets.

Purpose of the Study:

  • To highlight the convergence of two key SBDD approaches: docking and in situ molecular assembly.
  • To emphasize the fundamental role of structural information in advancing drug discovery.

Main Methods:

  • Review of current methodologies in SBDD.
  • Analysis of the integration of computational docking and in situ assembly techniques.

Main Results:

  • The technological advancements are leading to a merger of previously distinct SBDD strategies.

Related Experiment Videos

  • Structural insights into drug-protein complexes are becoming indispensable.

    • Conclusions:

    • The integration of docking and in situ assembly represents a significant evolution in SBDD.
    • Acquiring detailed structural information of drug-target interactions is paramount for efficient drug development.